MID-VOLUME · HOSP-HEAVY
bumetanide Side Effects
bumetanide (also sold as Bumex) sits MID-VOLUME #208 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 48.3% mention hospitalization (12,100 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 25,027
- FAERS reports
FDA Adverse Event Reporting System extract for bumetanide. Stamp set CASELOAD · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
bumetanide: 48.3% mention hospitalization (12,100 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #208 of 524 by FAERS report count.
Mid-book FAERS page for bumetanide (Bumex) (25,027 reports). Signature HOSP-HEAVY. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (1999–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DYSPNOEA leads 2,495 of 25,027 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (6,330 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,999 reports, 16.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,640 |
| DYSPNOEA | 388 |
| RENAL FAILURE | 378 |
| ACUTE KIDNEY INJURY | 312 |
| PNEUMONIA | 273 |
| CARDIAC FAILURE CONGESTIVE | 248 |
| CARDIAC FAILURE | 233 |
| CARDIAC ARREST | 205 |
| HYPOTENSION | 202 |
| CHRONIC KIDNEY DISEASE | 188 |
| ASTHENIA | 184 |
| RESPIRATORY FAILURE | 177 |
| PAIN | 175 |
| SEPSIS | 172 |
| ATRIAL FIBRILLATION | 169 |
| FALL | 166 |
| DIARRHOEA | 158 |
| FATIGUE | 151 |
| NAUSEA | 141 |
| VOMITING | 139 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (12,100, 48.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 1,650 |
| ACUTE KIDNEY INJURY | 1,150 |
| PNEUMONIA | 972 |
| FATIGUE | 790 |
| CARDIAC FAILURE CONGESTIVE | 779 |
| DIARRHOEA | 761 |
| HYPOTENSION | 715 |
| NAUSEA | 714 |
| ASTHENIA | 677 |
| FALL | 658 |
| DIZZINESS | 640 |
| RENAL FAILURE | 629 |
| ANAEMIA | 570 |
| CARDIAC FAILURE | 541 |
| VOMITING | 532 |
| OEDEMA PERIPHERAL | 529 |
| FLUID RETENTION | 524 |
| DEHYDRATION | 515 |
| HEADACHE | 505 |
| DEATH | 480 |
How to read bumetanide FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 25,027 voluntary reports linked to bumetanide (Bumex), 1999-2025. Death is listed on 3,999 (16.0%). Hospitalization appears on 12,100 (48.3%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 48.3% mention hospitalization (12,100 reports).
Read with bumetanide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 24,979 FAERS cases (Δ 48 lighter vs bumetanide); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 24,883 FAERS cases (Δ 144 lighter vs bumetanide); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 25,229 FAERS cases (Δ 202 heavier vs bumetanide); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 24,667 FAERS cases (Δ 360 lighter vs bumetanide); DEATH-MARKED · HOSP-LIGHT · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 46.1 pp vs bumetanide's DEATH-HEAVY): CASELOAD · HOSP-MID.
bumetanide stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.